“The Delta variant has become what we all hoped it would not” become, that is, the variant of Sars-CoV-2 dominant on the European continent. But approved Covid vaccines “remain effective”. There is some reduction, “but it is not significant”. To reassure is Emer Cooke, executive director of the European drug agency Ema, on ‘Politico.eu’. The expert also talks about the third dose, on which the debate is still open, while some countries, including Germany, have already decided to take this path, albeit starting from some specific population groups. “At the moment – said Cooke – there is not enough data to indicate that a recall is necessary”.
The situation is therefore monitored with the ECDC (European Center for the Prevention and Control of Diseases), the EMA is in constant contact with the companies on the node of the number of doses available, should another recall prove necessary. “For some populations – Cooke reasons – we could begin to see the need, which does not mean that there is a need for it universally in the whole population”.